0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Submucosal Injection Agent Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-5B10906
Home | Market Reports | Health| Medical Devices & Equipment
Global Submucosal Injection Agent Market Research Report 2022
BUY CHAPTERS

Global Submucosal Injection Agent Market Research Report 2025

Code: QYRE-Auto-5B10906
Report
January 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Submucosal Injection Agent Market Size

The global market for Submucosal Injection Agent was valued at US$ 105 million in the year 2024 and is projected to reach a revised size of US$ 175 million by 2031, growing at a CAGR of 7.7% during the forecast period.

Submucosal Injection Agent Market

Submucosal Injection Agent Market

Submucosal Injection Agent is a medical device that is an injectable liquid composition intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early stage cancers or other gastrointestinal mucosal lesions, prior to removal with a snare or endoscopic device.
It facilitates endoscopic resection procedures during endoscopic examinations in the upper and lower gastrointestinal tract, such as the esophagus, the stomach.
The global top five submucosal injection agent manufacturers include Seikagaku, Ovesco Endoscopy, GI Supply, Cosmo Pharmaceuticals, Boston Scientific, accounting for more than 60% of the market share, of which the largest manufacturer is Seikagaku, with a market share of more than 18%. North America is the most important submucosal injection agent consumer market in the world, with a market share of more than 32%. In terms of type, the market share of syringe type is more than 90%. In the application field, the market share of hospitals has reached more than 60%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Submucosal Injection Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Submucosal Injection Agent.
The Submucosal Injection Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Submucosal Injection Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Submucosal Injection Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Submucosal Injection Agent Market Report

Report Metric Details
Report Name Submucosal Injection Agent Market
Accounted market size in year US$ 105 million
Forecasted market size in 2031 US$ 175 million
CAGR 7.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Syringe Type
  • Ampoule Type
Segment by Application
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Seikagaku, Ovesco Endoscopy, GI Supply, Cosmo Pharmaceuticals, Boston Scientific, The Standard, Micro-Tech Endoscopy, EndoClot Plus
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Submucosal Injection Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Submucosal Injection Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Submucosal Injection Agent Market growing?

Ans: The Submucosal Injection Agent Market witnessing a CAGR of 7.7% during the forecast period 2025-2031.

What is the Submucosal Injection Agent Market size in 2031?

Ans: The Submucosal Injection Agent Market size in 2031 will be US$ 175 million.

What is the market share of major companies in Submucosal Injection Agent Market?

Ans: The global top five submucosal injection agent manufacturers include Seikagaku, Ovesco Endoscopy, GI Supply, Cosmo Pharmaceuticals, Boston Scientific, accounting for more than 60% of the market share, of which the largest manufacturer is Seikagaku, with a market share of more than 18%.

What is the Submucosal Injection Agent Market share by region?

Ans: North America is the most important submucosal injection agent consumer market in the world, with a market share of more than 32%.

What is the Submucosal Injection Agent Market share by type?

Ans: In terms of type, the market share of syringe type is more than 90%.

What is the Submucosal Injection Agent Market share by application?

Ans: In the application field, the market share of hospitals has reached more than 60%.

Who are the main players in the Submucosal Injection Agent Market report?

Ans: The main players in the Submucosal Injection Agent Market are Seikagaku, Ovesco Endoscopy, GI Supply, Cosmo Pharmaceuticals, Boston Scientific, The Standard, Micro-Tech Endoscopy, EndoClot Plus

What are the Application segmentation covered in the Submucosal Injection Agent Market report?

Ans: The Applications covered in the Submucosal Injection Agent Market report are Hospitals, Ambulatory Surgical Centers, Specialty Clinics

What are the Type segmentation covered in the Submucosal Injection Agent Market report?

Ans: The Types covered in the Submucosal Injection Agent Market report are Syringe Type, Ampoule Type

1 Submucosal Injection Agent Market Overview
1.1 Product Definition
1.2 Submucosal Injection Agent by Type
1.2.1 Global Submucosal Injection Agent Market Value Comparison by Type (2024 VS 2031)
1.2.2 Syringe Type
1.2.3 Ampoule Type
1.3 Submucosal Injection Agent by Application
1.3.1 Global Submucosal Injection Agent Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.4 Global Submucosal Injection Agent Market Size Estimates and Forecasts
1.4.1 Global Submucosal Injection Agent Revenue 2020-2031
1.4.2 Global Submucosal Injection Agent Sales 2020-2031
1.4.3 Global Submucosal Injection Agent Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Submucosal Injection Agent Market Competition by Manufacturers
2.1 Global Submucosal Injection Agent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Submucosal Injection Agent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Submucosal Injection Agent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Submucosal Injection Agent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Submucosal Injection Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Submucosal Injection Agent, Product Type & Application
2.7 Global Key Manufacturers of Submucosal Injection Agent, Date of Enter into This Industry
2.8 Global Submucosal Injection Agent Market Competitive Situation and Trends
2.8.1 Global Submucosal Injection Agent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Submucosal Injection Agent Players Market Share by Revenue
2.8.3 Global Submucosal Injection Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Submucosal Injection Agent Market Scenario by Region
3.1 Global Submucosal Injection Agent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Submucosal Injection Agent Sales by Region: 2020-2031
3.2.1 Global Submucosal Injection Agent Sales by Region: 2020-2025
3.2.2 Global Submucosal Injection Agent Sales by Region: 2026-2031
3.3 Global Submucosal Injection Agent Revenue by Region: 2020-2031
3.3.1 Global Submucosal Injection Agent Revenue by Region: 2020-2025
3.3.2 Global Submucosal Injection Agent Revenue by Region: 2026-2031
3.4 North America Submucosal Injection Agent Market Facts & Figures by Country
3.4.1 North America Submucosal Injection Agent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Submucosal Injection Agent Sales by Country (2020-2031)
3.4.3 North America Submucosal Injection Agent Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Submucosal Injection Agent Market Facts & Figures by Country
3.5.1 Europe Submucosal Injection Agent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Submucosal Injection Agent Sales by Country (2020-2031)
3.5.3 Europe Submucosal Injection Agent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Submucosal Injection Agent Market Facts & Figures by Region
3.6.1 Asia Pacific Submucosal Injection Agent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Submucosal Injection Agent Sales by Region (2020-2031)
3.6.3 Asia Pacific Submucosal Injection Agent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Submucosal Injection Agent Market Facts & Figures by Country
3.7.1 Latin America Submucosal Injection Agent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Submucosal Injection Agent Sales by Country (2020-2031)
3.7.3 Latin America Submucosal Injection Agent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Submucosal Injection Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Submucosal Injection Agent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Submucosal Injection Agent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Submucosal Injection Agent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Submucosal Injection Agent Sales by Type (2020-2031)
4.1.1 Global Submucosal Injection Agent Sales by Type (2020-2025)
4.1.2 Global Submucosal Injection Agent Sales by Type (2026-2031)
4.1.3 Global Submucosal Injection Agent Sales Market Share by Type (2020-2031)
4.2 Global Submucosal Injection Agent Revenue by Type (2020-2031)
4.2.1 Global Submucosal Injection Agent Revenue by Type (2020-2025)
4.2.2 Global Submucosal Injection Agent Revenue by Type (2026-2031)
4.2.3 Global Submucosal Injection Agent Revenue Market Share by Type (2020-2031)
4.3 Global Submucosal Injection Agent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Submucosal Injection Agent Sales by Application (2020-2031)
5.1.1 Global Submucosal Injection Agent Sales by Application (2020-2025)
5.1.2 Global Submucosal Injection Agent Sales by Application (2026-2031)
5.1.3 Global Submucosal Injection Agent Sales Market Share by Application (2020-2031)
5.2 Global Submucosal Injection Agent Revenue by Application (2020-2031)
5.2.1 Global Submucosal Injection Agent Revenue by Application (2020-2025)
5.2.2 Global Submucosal Injection Agent Revenue by Application (2026-2031)
5.2.3 Global Submucosal Injection Agent Revenue Market Share by Application (2020-2031)
5.3 Global Submucosal Injection Agent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Seikagaku
6.1.1 Seikagaku Company Information
6.1.2 Seikagaku Description and Business Overview
6.1.3 Seikagaku Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Seikagaku Submucosal Injection Agent Product Portfolio
6.1.5 Seikagaku Recent Developments/Updates
6.2 Ovesco Endoscopy
6.2.1 Ovesco Endoscopy Company Information
6.2.2 Ovesco Endoscopy Description and Business Overview
6.2.3 Ovesco Endoscopy Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ovesco Endoscopy Submucosal Injection Agent Product Portfolio
6.2.5 Ovesco Endoscopy Recent Developments/Updates
6.3 GI Supply
6.3.1 GI Supply Company Information
6.3.2 GI Supply Description and Business Overview
6.3.3 GI Supply Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GI Supply Submucosal Injection Agent Product Portfolio
6.3.5 GI Supply Recent Developments/Updates
6.4 Cosmo Pharmaceuticals
6.4.1 Cosmo Pharmaceuticals Company Information
6.4.2 Cosmo Pharmaceuticals Description and Business Overview
6.4.3 Cosmo Pharmaceuticals Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cosmo Pharmaceuticals Submucosal Injection Agent Product Portfolio
6.4.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.5 Boston Scientific
6.5.1 Boston Scientific Company Information
6.5.2 Boston Scientific Description and Business Overview
6.5.3 Boston Scientific Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Boston Scientific Submucosal Injection Agent Product Portfolio
6.5.5 Boston Scientific Recent Developments/Updates
6.6 The Standard
6.6.1 The Standard Company Information
6.6.2 The Standard Description and Business Overview
6.6.3 The Standard Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 The Standard Submucosal Injection Agent Product Portfolio
6.6.5 The Standard Recent Developments/Updates
6.7 Micro-Tech Endoscopy
6.7.1 Micro-Tech Endoscopy Company Information
6.7.2 Micro-Tech Endoscopy Description and Business Overview
6.7.3 Micro-Tech Endoscopy Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Micro-Tech Endoscopy Submucosal Injection Agent Product Portfolio
6.7.5 Micro-Tech Endoscopy Recent Developments/Updates
6.8 EndoClot Plus
6.8.1 EndoClot Plus Company Information
6.8.2 EndoClot Plus Description and Business Overview
6.8.3 EndoClot Plus Submucosal Injection Agent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 EndoClot Plus Submucosal Injection Agent Product Portfolio
6.8.5 EndoClot Plus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Submucosal Injection Agent Industry Chain Analysis
7.2 Submucosal Injection Agent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Submucosal Injection Agent Production Mode & Process Analysis
7.4 Submucosal Injection Agent Sales and Marketing
7.4.1 Submucosal Injection Agent Sales Channels
7.4.2 Submucosal Injection Agent Distributors
7.5 Submucosal Injection Agent Customer Analysis
8 Submucosal Injection Agent Market Dynamics
8.1 Submucosal Injection Agent Industry Trends
8.2 Submucosal Injection Agent Market Drivers
8.3 Submucosal Injection Agent Market Challenges
8.4 Submucosal Injection Agent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Submucosal Injection Agent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Submucosal Injection Agent Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Submucosal Injection Agent Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Submucosal Injection Agent Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Submucosal Injection Agent Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Submucosal Injection Agent Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Submucosal Injection Agent Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Submucosal Injection Agent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Submucosal Injection Agent, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Submucosal Injection Agent, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Submucosal Injection Agent, Product Type & Application
 Table 12. Global Key Manufacturers of Submucosal Injection Agent, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Submucosal Injection Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Submucosal Injection Agent as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Submucosal Injection Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Submucosal Injection Agent Sales by Region (2020-2025) & (K Units)
 Table 18. Global Submucosal Injection Agent Sales Market Share by Region (2020-2025)
 Table 19. Global Submucosal Injection Agent Sales by Region (2026-2031) & (K Units)
 Table 20. Global Submucosal Injection Agent Sales Market Share by Region (2026-2031)
 Table 21. Global Submucosal Injection Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Submucosal Injection Agent Revenue Market Share by Region (2020-2025)
 Table 23. Global Submucosal Injection Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Submucosal Injection Agent Revenue Market Share by Region (2026-2031)
 Table 25. North America Submucosal Injection Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Submucosal Injection Agent Sales by Country (2020-2025) & (K Units)
 Table 27. North America Submucosal Injection Agent Sales by Country (2026-2031) & (K Units)
 Table 28. North America Submucosal Injection Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Submucosal Injection Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Submucosal Injection Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Submucosal Injection Agent Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Submucosal Injection Agent Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Submucosal Injection Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Submucosal Injection Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Submucosal Injection Agent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Submucosal Injection Agent Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Submucosal Injection Agent Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Submucosal Injection Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Submucosal Injection Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Submucosal Injection Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Submucosal Injection Agent Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Submucosal Injection Agent Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Submucosal Injection Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Submucosal Injection Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Submucosal Injection Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Submucosal Injection Agent Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Submucosal Injection Agent Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Submucosal Injection Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Submucosal Injection Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Submucosal Injection Agent Sales (K Units) by Type (2020-2025)
 Table 51. Global Submucosal Injection Agent Sales (K Units) by Type (2026-2031)
 Table 52. Global Submucosal Injection Agent Sales Market Share by Type (2020-2025)
 Table 53. Global Submucosal Injection Agent Sales Market Share by Type (2026-2031)
 Table 54. Global Submucosal Injection Agent Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Submucosal Injection Agent Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Submucosal Injection Agent Revenue Market Share by Type (2020-2025)
 Table 57. Global Submucosal Injection Agent Revenue Market Share by Type (2026-2031)
 Table 58. Global Submucosal Injection Agent Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Submucosal Injection Agent Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Submucosal Injection Agent Sales (K Units) by Application (2020-2025)
 Table 61. Global Submucosal Injection Agent Sales (K Units) by Application (2026-2031)
 Table 62. Global Submucosal Injection Agent Sales Market Share by Application (2020-2025)
 Table 63. Global Submucosal Injection Agent Sales Market Share by Application (2026-2031)
 Table 64. Global Submucosal Injection Agent Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Submucosal Injection Agent Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Submucosal Injection Agent Revenue Market Share by Application (2020-2025)
 Table 67. Global Submucosal Injection Agent Revenue Market Share by Application (2026-2031)
 Table 68. Global Submucosal Injection Agent Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Submucosal Injection Agent Price (US$/Unit) by Application (2026-2031)
 Table 70. Seikagaku Company Information
 Table 71. Seikagaku Description and Business Overview
 Table 72. Seikagaku Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Seikagaku Submucosal Injection Agent Product
 Table 74. Seikagaku Recent Developments/Updates
 Table 75. Ovesco Endoscopy Company Information
 Table 76. Ovesco Endoscopy Description and Business Overview
 Table 77. Ovesco Endoscopy Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Ovesco Endoscopy Submucosal Injection Agent Product
 Table 79. Ovesco Endoscopy Recent Developments/Updates
 Table 80. GI Supply Company Information
 Table 81. GI Supply Description and Business Overview
 Table 82. GI Supply Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GI Supply Submucosal Injection Agent Product
 Table 84. GI Supply Recent Developments/Updates
 Table 85. Cosmo Pharmaceuticals Company Information
 Table 86. Cosmo Pharmaceuticals Description and Business Overview
 Table 87. Cosmo Pharmaceuticals Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Cosmo Pharmaceuticals Submucosal Injection Agent Product
 Table 89. Cosmo Pharmaceuticals Recent Developments/Updates
 Table 90. Boston Scientific Company Information
 Table 91. Boston Scientific Description and Business Overview
 Table 92. Boston Scientific Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Boston Scientific Submucosal Injection Agent Product
 Table 94. Boston Scientific Recent Developments/Updates
 Table 95. The Standard Company Information
 Table 96. The Standard Description and Business Overview
 Table 97. The Standard Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. The Standard Submucosal Injection Agent Product
 Table 99. The Standard Recent Developments/Updates
 Table 100. Micro-Tech Endoscopy Company Information
 Table 101. Micro-Tech Endoscopy Description and Business Overview
 Table 102. Micro-Tech Endoscopy Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Micro-Tech Endoscopy Submucosal Injection Agent Product
 Table 104. Micro-Tech Endoscopy Recent Developments/Updates
 Table 105. EndoClot Plus Company Information
 Table 106. EndoClot Plus Description and Business Overview
 Table 107. EndoClot Plus Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. EndoClot Plus Submucosal Injection Agent Product
 Table 109. EndoClot Plus Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Submucosal Injection Agent Distributors List
 Table 113. Submucosal Injection Agent Customers List
 Table 114. Submucosal Injection Agent Market Trends
 Table 115. Submucosal Injection Agent Market Drivers
 Table 116. Submucosal Injection Agent Market Challenges
 Table 117. Submucosal Injection Agent Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Submucosal Injection Agent
 Figure 2. Global Submucosal Injection Agent Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Submucosal Injection Agent Market Share by Type: 2024 & 2031
 Figure 4. Syringe Type Product Picture
 Figure 5. Ampoule Type Product Picture
 Figure 6. Global Submucosal Injection Agent Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Submucosal Injection Agent Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Ambulatory Surgical Centers
 Figure 10. Specialty Clinics
 Figure 11. Global Submucosal Injection Agent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Submucosal Injection Agent Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Submucosal Injection Agent Sales (2020-2031) & (K Units)
 Figure 14. Global Submucosal Injection Agent Average Price (US$/Unit) & (2020-2031)
 Figure 15. Submucosal Injection Agent Report Years Considered
 Figure 16. Submucosal Injection Agent Sales Share by Manufacturers in 2024
 Figure 17. Global Submucosal Injection Agent Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Submucosal Injection Agent Players: Market Share by Revenue in Submucosal Injection Agent in 2024
 Figure 19. Submucosal Injection Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Submucosal Injection Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Submucosal Injection Agent Sales Market Share by Country (2020-2031)
 Figure 22. North America Submucosal Injection Agent Revenue Market Share by Country (2020-2031)
 Figure 23. United States Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Submucosal Injection Agent Sales Market Share by Country (2020-2031)
 Figure 26. Europe Submucosal Injection Agent Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Submucosal Injection Agent Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Submucosal Injection Agent Revenue Market Share by Region (2020-2031)
 Figure 34. China Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Submucosal Injection Agent Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Submucosal Injection Agent Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Submucosal Injection Agent Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Submucosal Injection Agent Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Submucosal Injection Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Submucosal Injection Agent by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Submucosal Injection Agent by Type (2020-2031)
 Figure 55. Global Submucosal Injection Agent Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Submucosal Injection Agent by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Submucosal Injection Agent by Application (2020-2031)
 Figure 58. Global Submucosal Injection Agent Price (US$/Unit) by Application (2020-2031)
 Figure 59. Submucosal Injection Agent Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Fast Protein-free Blocking Buffer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18R18881
Fri Jan 31 00:00:00 UTC 2025

Add to Cart

Global Hard Oxygen Chamber Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35N18718
Fri Jan 31 00:00:00 UTC 2025

Add to Cart

Global Prefillable COP Polymer Syringes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2C19012
Fri Jan 31 00:00:00 UTC 2025

Add to Cart

Global Soft Oxygen Chamber Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38V18597
Fri Jan 31 00:00:00 UTC 2025

Add to Cart